Sun Exposure and Activities After Skin Cancer: Optimization of mHealth Interventions

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorNorthwestern University

About this trial

The purpose of this study is to evaluate 5 different smartphone administered sun protection interventions that aim to reduce unprotected sun exposure in melanoma survivors. Participants are asked to wear an ultraviolet (UV) device and an activity monitor (Actigraph) to measure their daily UV exposure and track their physical activity for three separate assessment weeks and complete daily surveys. After the first assessment week, eligible participants are assigned up to 5 different sun protection interventions that are administered through a smartphone application for 8 weeks. Following 8-week use of the sun protection interventions, participants complete another assessment week. At the end of the assessment week, participants provide feedback on the design and usability of the UV device, smartphone application and each of the sun protection interventions that they experienced. One year later, participants are contacted again to complete a final assessment week.

Eligibility criteria

Qualifiers

Is able to speak, read and write in English

Had previous melanoma diagnosis with no melanoma treatment in the last three months

Has no current Melanomas or untreated skin cancer

Reports spending at least 15 minutes outside per day during Spring/ Summer on both weekdays and weekends

Disqualifiers

Has a medical condition preventing moderate-to-vigorous physical activity (MVPA) or a doctor recommendation to avoid MVPA

Is currently enrolled in another study on MVPA

Trial design

Treatments tested in this trial

  • UV Real-Time Alerts
  • Track Your Sun Protection
  • Current Conditions
  • Health Coaching
  • Action Planning
  • Core Components

Treatment groups

150 Participants
are divided into 32 treatment groups

32

Treatment groups

See each treatment group below.

Sponsors and collaborators

Northwestern University

Lead sponsor

National Institutes of Health (NIH)

Collaborator

Huntsman Cancer Institute/ University of Utah

Collaborator

National Cancer Institute (NCI)

Collaborator